Monday 16 June 2025
  • About
  • Contact
  • Login
  • VC & Investment
  • M&A
  • AI
  • Podcasts
  • News
    • Pharmaceutical News
    • Biotechnology News
    • Generics News
    • Biosimilars news
    • In Brief
    • Legal
    • Company Pages
    • In The Boardroom
  • Insights
    • Analysis
    • Special Report
    • Interviews
    • Expert View
    • From Our Correspondent
    • One To Watch Companies
    • Digital Pharma
    • Pharma Leaders
  • Regulatory
    • FDA
    • EMA
    • Pricing, Reimbursement and Access
    • Regulation
    • Government Affairs
    • Trump Administration
  • Therapy Areas
    • Dermatologicals
    • Oncology
    • Neurological
    • Rare Diseases
    • Hematology
    • Cardio Vascular
    • Diabetes
    • Cell And Gene Therapy
  • Conferences
    • JPM Healthcare Conference
    • ESMO
    • ASCO
    • ASH
    • EULAR
    • AAIC
    • EASD
    • Forthcoming Events
  • Ones to Watch
  • About
  • Contact
  • Newsletter
  • Sign inSubscribe
Subscribe
  • Home
  • J.P. Morgan Healthcare Conference

J.P. Morgan Healthcare Conference

Visit event website
13 January 202516 January 2025
California, USAThe Westin St. Francis
A leading health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

The Conference is the industry’s biggest gathering, bringing together more than 8,000 investors, industry professionals, senior government officials and 550 global health care companies — ranging from Fortune 100 corporations to small-cap and emerging private companies — to discuss the latest market trends and medical innovations.



Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news

Today's issue

The week in pharma: action, reaction and insight – week to June 13
Biotechnology
The week in pharma: action, reaction and insight – week to June 13
15 June 2025
Pharmaceutical
FDA won’t meet PDUFA goal date for sebetralstat
14 June 2025
Pharmaceutical
UK-led vaccine bond scheme passes $10 billion milestone
14 June 2025
Pharmaceutical
AstraZeneca goes Chinese again in monster AI collaboration
13 June 2025
Biotechnology
Celldex keeps climbing on barzolvolimab’s effect in urticaria
13 June 2025
Biotechnology
FDA approves Keytruda for yet another indication
13 June 2025
Pharmaceutical
Merck KGaA sees future for enpatoran in lupus subgroup
13 June 2025

Company Spotlight

An American biotech company developing solutions that treat urothelial and specialty cancers.




The Pharma Letter

39-43 Putney High Street, Putney
London, SW15 1SP
United Kingdom

  • About us
  • Contact
  • Subscribe
  • Sponsorship/advertising


  • Terms and Conditions
  • Privacy Policy
  • Twitter
  • Linkedin

Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze